Le Lézard
Classified in: Health
Subject: CFG

Public Health Agency of Canada Confirms 2 cases of Monkeypox


OTTAWA, ON , May 19, 2022 /CNW/ - The Public Health Agency of Canada (PHAC) is working with the United States Centers for Disease Control and Prevention, and public health authorities in the province of Quebec to investigate potential exposure and contacts of a case of monkeypox recently identified in the United States (U.S.). The U.S. citizen had recently travelled to Canada from the U.S. The individual travelled by private transportation and may have been infected before or during his visit to Montreal, Quebec.

As part of the ongoing investigation, health partners have identified individuals in Canada who have signs and symptoms which could be consistent with monkeypox infection. The National Microbiology Laboratory (NML) is undertaking additional testing to confirm or rule out a diagnosis of monkeypox for these individuals. Tonight, the Province of Quebec was notified that two samples received by the NML have tested positive for monkeypox. These are the first two cases confirmed in Canada.

Monkeypox is a zoonotic infectious disease found in parts of central and West Africa that result in occasional human infections usually associated with exposure to infected animals or contaminated materials. Limited cases have been identified in other regions in the past, including the United Kingdom, United States, Israel and Singapore, but never before in Canada. For the recent international cases, it is not yet certain how the individuals were exposed to monkeypox virus.

Person to person spread of monkeypox is uncommon. However, when spread does occur between people the mode of transmission is through close contact with an infected individual, such as through direct contact with their body fluids, respiratory droplets, or monkeypox sores, or by sharing clothing, bedding or common items that have been contaminated with the infected person's fluids or sores. As with many other diseases spread through close contact, people can lower their risk by maintaining physical distance, frequent hand and respiratory hygiene including masking.

People should be aware of the symptoms of monkeypox and report any concerns to their health care provider. Signs and symptoms of monkeypox can typically include fever, headache, muscle aches, exhaustion, and swollen lymph nodes, and a rash that often appears within a few days after symptoms such as fever develop.

PHAC has alerted public health authorities to work with health care providers to look for patients who have signs or symptoms consistent with monkeypox, regardless of whether they have reported travel or have specific risk factors for monkeypox.

This is an evolving and ongoing investigation, both in Canada and around the world. More information is needed to assess if there are increased health risks to people in Canada. PHAC will continue to provide updates to the public as new information becomes available.

SOURCE Public Health Agency of Canada


These press releases may also interest you

at 10:25
Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2 therapeutics, today announced that updated Phase 1/2 data for AU-007 will be presented at the American Society...

at 10:20
A monument park and website honoring medical frontline and essential workers worldwide who risked their lives during the COVID-19 pandemic will break ground this summer in Chicago, Illinois. The COVID-19 Monument of Honor, Remembrance, and Resilience...

at 10:20
Precigen, Inc. , a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced clinical data from the pivotal Phase 2 study of PRGN-2012 AdenoVerse immunotherapy...

at 10:20
The two poster presentations will report -first combination data from the Phase 1/2a study with BI-1808 in combination with MSD's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), as well as an update on monotherapy armcombination data from the...

at 10:15
Sheppard, Mullin, Richter & Hampton LLP is pleased to announce that Kwan-Ho "Alex" Chung, Ph.D. has joined the firm's Intellectual Property practice group and Life Sciences industry team in Washington, D.C. Chung was most recently a partner at...

at 10:15
For nearly 40 years Burke Williams has been an innovator and leader in the luxury day spa industry, and in 2024 the company is continuing to deliver relaxing, rejuvenating experiences for guests that truly transform their day....



News published on and distributed by: